Jambes Légères
Food supplement declared in France, declaration No 2020-6-96
Jambes Légères is a food supplement declared in France. Status: retiré du marché le 1 April 2023. 1 rule of use applies to its ingredients (limits and warnings).
- Brand
- not provided
- Food business operator placing the product on the market
- IBSA Pharma SAS
- Status
- Retiré du marché le 1 April 2023
- Form
- Comprimé
- Daily dose
- 2 comprimés par jour
- Directions for use
- 1 comprimé à avaler ou à croquer, midi et soir au moment des repas
- Not recommended for (according to the manufacturer)
- Femmes allaitantes, Enfants (moins de 12 ans), Femmes enceintes, Sous traitement antihypertenseur
- Objectives stated by the manufacturer (these are not authorised claims)
- Circulation sanguine et lymphatique
Declaration 308012, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
- Conditions légales
Citrus aurantium L.: La quantité ingérée de p-synéphrine doit être inférieure à 20 mg par dose journalière recommandée. L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants, aux femmes enceintes ou allaitantes et en cas de traitement anti-hypertenseur. La caféine et les sources de caféine ne sont pas autorisées dans les compléments alimentaires contenant Citrus aurantium L.
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
- Information
Retiré du marché le 1 April 2023, according to Compl'Alim.
Source: Compl'Alim, food supplement declarations (France).
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Vitis vinifera L. | Feuille | Extrait sec aqueux | 260 mg |
| Citrus aurantium L. | Péricarpe | Extrait sec aqueux | 70 mg |
Additives
E504, E553b
Other ingredients
maltodextrine
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Label warnings
Cesser l'utilisation du produit en cas d'agitation ou de nervosité.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Other declarations with the same name
This name is used by more than 10 declarations from different companies, so it does not identify one product. See every declaration with this name.